Neurovascular Thrombectomy Devices Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2030, Segmented By Device Type (Aspiration Devices, Stent Retrievers, Mechanical Embolus Removal Devices, Suction Devices, Others); By Indication (Ischemic Stroke, Hemorrhagic Stroke, Others); By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Others); By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)
Global Neurovascular Thrombectomy Devices Market Size Set to Expand at Significant CAGR of 6.88% to Reach USD 4.08 Billion by 2030
Global Neurovascular Thrombectomy Devices Market is flourishing because of growing awareness about the treatment and management of stroke, rising prevalence of stroke, and an increasing focus on improved diagnosis.
BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the Global Neurovascular Thrombectomy Devices Market size at USD 2.17 billion in 2023. During the forecast period between 2024 and 2030, BlueWeave expects the Global Neurovascular Thrombectomy Devices Market size to expand at a CAGR of 6.88% reaching a value of USD 4.08 billion by 2030. The growing incidence of neurovascular illnesses and the expanding need for efficient treatment options are key drivers of growth for the Global Neurovascular Thrombectomy Devices Market. Furthermore, during the period in analysis, the market is expected to witness lucrative opportunities due to the expansion of research and development activities in the field of interventional neurology.
Opportunity - Rising accessibility to healthcare facilities
The Global Neurovascular Thrombectomy Devices Market is segmented into hospitals, ambulatory surgical centers, specialty clinics, and others, based on end user. The hospitals segment holds the largest market share, mainly due to the high number of patients with neovascular diseases approaching hospitals for the diagnosis and treatment of various conditions. The increasing number of hospitals, particularly in emerging economies, such as India and China, owing to healthcare infrastructure growth, is anticipated to drive the hospital segment in the Global Neurovascular Thrombectomy Devices Market during the period in analysis.
Impact of Escalating Geopolitical Tensions on Global Neurovascular Thrombectomy Devices Market
The escalating geopolitical tensions hindered the growth of Global Neurovascular Thrombectomy Devices Market. The Russia-Ukraine war, began in February 2022, abruptly put the Ukraine's healthcare sector under tremendous strain and presented unprecedented difficulties. Bombs destroyed buildings and interfered with the delivery of healthcare services. Routine preventive checkups were hindered due to the inaccessibility of healthcare professionals, which resulted in a decline in the diagnosis rate of neurovascular diseases. In Palestine, healthcare facilities have been facing a similar situation, which directly impacts the demand for neurovascular thrombectomy devices, limiting its market growth in these regions.
Global Neurovascular Thrombectomy Devices Market
Segmental Coverage
Global Neurovascular Thrombectomy Devices Market – By Indication
Based on the indication, the Global Neurovascular Thrombectomy Devices Market is segmented into ischemic stroke, hemorrhagic stroke, and others. The ischemic stroke segment accounts for the highest share in the Global Neurovascular Thrombectomy Devices Market owing to its high prevalence worldwide. According to the World Stroke Organization, ischemic strokes account for more than 62% of all stroke incidents globally. The rising focus and investments to develop advanced neurovascular thrombectomy devices is expected to provide lucrative growth opportunities to the market players.
Global Neurovascular Thrombectomy Devices Market – By Region
The in-depth research report on the Global Neurovascular Thrombectomy Devices Market covers a number of country-specific markets across five major regions: North America, Europe, Asia Pacific (APAC), Latin America, and Middle East and Africa. North America dominates the Global Neurovascular Thrombectomy Devices Market. The increasing burden of neurovascular diseases, rising expenditure in healthcare, and growth in ambulatory care facilities are directly influencing the growth of the market in North America. Furthermore, favorable reimbursement policies for various neurovascular conditions also contribute to the growth of the Neurovascular Thrombectomy Devices Market in North America.
Competitive Landscape
Major players operating in the Global Neurovascular Thrombectomy Devices Market include Acandis GmbH, Penumbra, Inc., Medtronic, VESALIO, LLC, Johnson & Johnson, MicroVention, Inc., Phenox GmbH, Imperative Care, Inc., Balt Group, NeuroVasc Technologies, Inc., Baylis Medical Company, Inc., Boston Scientific Corporation, Terumo Corporation, Spectranetics Corporation, Edwards Lifesciences Corporation, Argon Medical Devices, Inc., and Teleflex Incorporated.
To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.
The in-depth analysis of the report provides information about growth potential, upcoming trends, and the Global Neurovascular Thrombectomy Devices Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the Global Neurovascular Thrombectomy Devices Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.
- 1. Research Framework
- 1.1. Research Objective
- 1.2. Product Overview
- 1.3. Market Segmentation
- 2. Executive Summary
- 3. Global Neurovascular Thrombectomy Devices Market Insights
- 3.1. Industry Value Chain Analysis
- 3.2. DROC Analysis
- 3.2.1. Growth Drivers
- 3.2.1.1. Rising Prevalence of Stroke
- 3.2.1.2. Growing Geriatric Population
- 3.2.1.3. Increasing Awareness and Improved Diagnosis
- 3.2.1.4. Favorable Reimbursement Policies
- 3.2.2. Restraints
- 3.2.2.1. High Cost of Devices
- 3.2.2.2. Limited Medical Expertise
- 3.2.2.3. Stringent Regulatory Requirements
- 3.2.3. Opportunities
- 3.2.3.1. Technological Advancements
- 3.2.3.2. Emerging Markets
- 3.2.3.3. Focus on Minimally Invasive Procedures
- 3.2.4. Challenges
- 3.2.4.1. Maintaining Procedural Efficiency
- 3.2.4.2. Reimbursement Challenges in Many Countries
- 3.2.4.3. Increased Competition
- 3.3. Technological Advancements/Recent Developments
- 3.4. Regulatory Framework
- 3.5. Porter’s Five Forces Analysis
- 3.5.1. Bargaining Power of Suppliers
- 3.5.2. Bargaining Power of Buyers
- 3.5.3. Threat of New Entrants
- 3.5.4. Threat of Substitutes
- 3.5.5. Intensity of Rivalry
- 4. Global Neurovascular Thrombectomy Devices Market: Marketing Strategies
- 5. Global Neurovascular Thrombectomy Devices Market Overview
- 5.1. Market Size & Forecast, 2019–2030
- 5.1.1. By Value (USD Billion)
- 5.2. Market Share and Forecast
- 5.2.1. By Device Type
- 5.2.1.1. Aspiration Devices
- 5.2.1.2. Stent Retrievers
- 5.2.1.3. Mechanical Embolus Removal Devices
- 5.2.1.4. Suction Devices
- 5.2.1.5. Others
- 5.2.2. By Indication
- 5.2.2.1. Ischemic Stroke
- 5.2.2.2. Hemorrhagic Stroke
- 5.2.2.3. Others
- 5.2.3. By End User
- 5.2.3.1. Hospitals
- 5.2.3.2. Ambulatory Surgical Centers
- 5.2.3.3. Specialty Clinics
- 5.2.3.4. Others
- 5.2.4. By Region
- 5.2.4.1. North America
- 5.2.4.2. Europe
- 5.2.4.3. Asia Pacific (APAC)
- 5.2.4.4. Latin America (LATAM)
- 5.2.4.5. Middle East and Africa (MEA)
- 6. North America Neurovascular Thrombectomy Devices Market
- 6.1. Market Size & Forecast, 2019–2030
- 6.1.1. By Value (USD Billion)
- 6.2. Market Share & Forecast
- 6.2.1. By Device Type
- 6.2.2. By Indication
- 6.2.3. By End User
- 6.2.4. By Country
- 6.2.4.1. United States
- 6.2.4.1.1. By Device Type
- 6.2.4.1.2. By Indication
- 6.2.4.1.3. By End User
- 6.2.4.2. Canada
- 6.2.4.2.1. By Device Type
- 6.2.4.2.2. By Indication
- 6.2.4.2.3. By End User
- 7. Europe Neurovascular Thrombectomy Devices Market
- 7.1. Market Size & Forecast, 2019–2030
- 7.1.1. By Value (USD Billion)
- 7.2. Market Share & Forecast
- 7.2.1. By Device Type
- 7.2.2. By Indication
- 7.2.3. By End User
- 7.2.4. By Country
- 7.2.4.1. Germany
- 7.2.4.1.1. By Device Type
- 7.2.4.1.2. By Indication
- 7.2.4.1.3. By End User
- 7.2.4.2. United Kingdom
- 7.2.4.2.1. By Device Type
- 7.2.4.2.2. By Indication
- 7.2.4.2.3. By End User
- 7.2.4.3. Italy
- 7.2.4.3.1. By Device Type
- 7.2.4.3.2. By Indication
- 7.2.4.3.3. By End User
- 7.2.4.4. France
- 7.2.4.4.1. By Device Type
- 7.2.4.4.2. By Indication
- 7.2.4.4.3. By End User
- 7.2.4.5. Spain
- 7.2.4.5.1. By Device Type
- 7.2.4.5.2. By Indication
- 7.2.4.5.3. By End User
- 7.2.4.6. Belgium
- 7.2.4.6.1. By Device Type
- 7.2.4.6.2. By Indication
- 7.2.4.6.3. By End User
- 7.2.4.7. Russia
- 7.2.4.7.1. By Device Type
- 7.2.4.7.2. By Indication
- 7.2.4.7.3. By End User
- 7.2.4.8. The Netherlands
- 7.2.4.8.1. By Device Type
- 7.2.4.8.2. By Indication
- 7.2.4.8.3. By End User
- 7.2.4.9. Rest of Europe
- 7.2.4.9.1. By Device Type
- 7.2.4.9.2. By Indication
- 7.2.4.9.3. By End User
- 8. Asia Pacific Neurovascular Thrombectomy Devices Market
- 8.1. Market Size & Forecast, 2019–2030
- 8.1.1. By Value (USD Billion)
- 8.2. Market Share & Forecast
- 8.2.1. By Device Type
- 8.2.2. By Indication
- 8.2.3. By End User
- 8.2.4. By Country
- 8.2.4.1. China
- 8.2.4.1.1. By Device Type
- 8.2.4.1.2. By Indication
- 8.2.4.1.3. By End User
- 8.2.4.2. India
- 8.2.4.2.1. By Device Type
- 8.2.4.2.2. By Indication
- 8.2.4.2.3. By End User
- 8.2.4.3. Japan
- 8.2.4.3.1. By Device Type
- 8.2.4.3.2. By Indication
- 8.2.4.3.3. By End User
- 8.2.4.4. South Korea
- 8.2.4.4.1. By Device Type
- 8.2.4.4.2. By Indication
- 8.2.4.4.3. By End User
- 8.2.4.5. Australia & New Zealand
- 8.2.4.5.1. By Device Type
- 8.2.4.5.2. By Indication
- 8.2.4.5.3. By End User
- 8.2.4.6. Indonesia
- 8.2.4.6.1. By Device Type
- 8.2.4.6.2. By Indication
- 8.2.4.6.3. By End User
- 8.2.4.7. Malaysia
- 8.2.4.7.1. By Device Type
- 8.2.4.7.2. By Indication
- 8.2.4.7.3. By End User
- 8.2.4.8. Singapore
- 8.2.4.8.1. By Device Type
- 8.2.4.8.2. By Indication
- 8.2.4.8.3. By End User
- 8.2.4.9. Vietnam
- 8.2.4.9.1. By Device Type
- 8.2.4.9.2. By Indication
- 8.2.4.9.3. By End User
- 8.2.4.10. Rest of APAC
- 8.2.4.10.1. By Device Type
- 8.2.4.10.2. By Indication
- 8.2.4.10.3. By End User
- 9. Latin America Neurovascular Thrombectomy Devices Market
- 9.1. Market Size & Forecast, 2019–2030
- 9.1.1. By Value (USD Billion)
- 9.2. Market Share & Forecast
- 9.2.1. By Device Type
- 9.2.2. By Indication
- 9.2.3. By End User
- 9.2.4. By Country
- 9.2.4.1. Brazil
- 9.2.4.1.1. By Device Type
- 9.2.4.1.2. By Indication
- 9.2.4.1.3. By End User
- 9.2.4.2. Mexico
- 9.2.4.2.1. By Device Type
- 9.2.4.2.2. By Indication
- 9.2.4.2.3. By End User
- 9.2.4.3. Argentina
- 9.2.4.3.1. By Device Type
- 9.2.4.3.2. By Indication
- 9.2.4.3.3. By End User
- 9.2.4.4. Peru
- 9.2.4.4.1. By Device Type
- 9.2.4.4.2. By Indication
- 9.2.4.4.3. By End User
- 9.2.4.5. Rest of LATAM
- 9.2.4.5.1. By Device Type
- 9.2.4.5.2. By Indication
- 9.2.4.5.3. By End User
- 10. Middle East and Africa Neurovascular Thrombectomy Devices Market
- 10.1. Market Size & Forecast, 2019–2030
- 10.1.1. By Value (USD Billion)
- 10.2. Market Share & Forecast
- 10.2.1. By Device Type
- 10.2.2. By Indication
- 10.2.3. By End User
- 10.2.4. By Country
- 10.2.4.1. Saudi Arabia
- 10.2.4.1.1. By Device Type
- 10.2.4.1.2. By Indication
- 10.2.4.1.3. By End User
- 10.2.4.2. UAE
- 10.2.4.2.1. By Device Type
- 10.2.4.2.2. By Indication
- 10.2.4.2.3. By End User
- 10.2.4.3. Qatar
- 10.2.4.3.1. By Device Type
- 10.2.4.3.2. By Indication
- 10.2.4.3.3. By End User
- 10.2.4.4. Kuwait
- 10.2.4.4.1. By Device Type
- 10.2.4.4.2. By Indication
- 10.2.4.4.3. By End User
- 10.2.4.5. South Africa
- 10.2.4.5.1. By Device Type
- 10.2.4.5.2. By Indication
- 10.2.4.5.3. By End User
- 10.2.4.6. Nigeria
- 10.2.4.6.1. By Device Type
- 10.2.4.6.2. By Indication
- 10.2.4.6.3. By End User
- 10.2.4.7. Algeria
- 10.2.4.7.1. By Device Type
- 10.2.4.7.2. By Indication
- 10.2.4.7.3. By End User
- 10.2.4.8. Rest of MEA
- 10.2.4.8.1. By Device Type
- 10.2.4.8.2. By Indication
- 10.2.4.8.3. By End User
- 11. Competitive Landscape
- 11.1. List of Key Players and Their Offerings
- 11.2. Global Neurovascular Thrombectomy Devices Market Share Analysis, 2023
- 11.3. Competitive Benchmarking, By Operating Parameters
- 11.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
- 12. Impact of Escalating Geopolitical Tensions on Global Neurovascular Thrombectomy Devices Market
- 13. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)
- 13.1. Acandis GmbH
- 13.2. Penumbra, Inc.
- 13.3. Medtronic
- 13.4. VESALIO, LLC
- 13.5. Johnson and Johnson
- 13.6. MicroVention, Inc.
- 13.7. Phenox GmbH
- 13.8. Imperative Care, Inc.
- 13.9. Balt Group
- 13.10. NeuroVasc Technologies, Inc.
- 13.11. Baylis Medical Company, Inc.
- 13.12. Boston Scientific Corporation
- 13.13. Terumo Corporation
- 13.14. Spectranetics Corporation
- 13.15. Edwards Lifesciences Corporation
- 13.16. Argon Medical Devices, Inc
- 13.17. Teleflex Incorporated
- 13.18. Other Prominent Players
- 14. Key Strategic Recommendations
- 15. Research Methodology
- 15.1. Qualitative Research
- 15.1.1. Primary & Secondary Research
- 15.2. Quantitative Research
- 15.3. Market Breakdown & Data Triangulation
- 15.3.1. Secondary Research
- 15.3.2. Primary Research
- 15.4. Breakdown of Primary Research Respondents, By Region
- 15.5. Assumptions & Limitations
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook